FDA Expands Use Of Pfizer's Ibrance, Attack On Titan, Spectrum Gets FDA Date

Shares of Titan Pharmaceuticals Inc. (TTNP) continued to fall in extended trading too on Friday as Probuphine, the company's investigational subdermal implant to treat opioid addiction, faces another FDA delay.

from RTT - Biotech http://ift.tt/1Uh6XcR
via IFTTT